Ascend Wellness to acquire Ohio Patient, Toronto’s new LIT Research facility opens, Relief for Czech patients is near
Ascend Wellness Holdings Inc has entered into a definitive agreement with Ohio Patient Access LLC for the option of 100% acquisition of 3 provisionally licensed dispensaries. The acquisition would bring Ascend Wellness up to 5 operating locations, the maximum allowed by state regulations.
“This transaction represents an ideal opportunity to maximize our dispensary footprint in Ohio, a state that has near-term potential for adult-use cannabis sales,” announced Abner Kurtin, Chief Executive Officer, Chairman, and Founder of Ascend. “Going deep in the states in which we operate and being a top provider in each state is critical to sustainable growth and margin expansion. “
Press release: https://www.newswire.ca/news-releases/awh-enters-definitive-agreement-providing-the-option-to-acquire-ohio-patient-access-llc-856850787.html
Pure Sunfarms and Simon Fraser University have extended their research partnership for another three years. The partnership has led to identification of pathogens affecting greenhouse grown cannabis and development of control strategies.
“At Pure Sunfarms, we believe in supporting academics to learn more about the cannabis plant and what keeps it healthy – we’re a flower-first company, and we know it all starts with the plant,” stated Mandesh Dosanjh, President and CEO of Pure Sunfarms. “Dr Punja’s work has helped us promote plant health and through this continued partnership with SFU, we look forward to unearthing research findings that will allow us to continue to optimize the quality of our flower while upholding British Columbia’s proud heritage as one of the world’s best cultivators of cannabis.”
Press release: https://www.globenewswire.com/en/news-release/2022/08/17/2500172/0/en/Pure-Sunfarms-extends-partnership-with-Simon-Fraser-University-to-advance-cannabis-research.html
Cannadigm Corp is thrilled to announce the license receipt for its Toronto testing facility. The Health Canada research license allows administration of cannabis for sensitivity testing research in adults.
“LIT Research is an immersive education-focused cannabis testing experience in the heart of downtown Toronto. Our team of highly knowledgeable and experienced cannabis industry professionals design and conduct consumer studies to evaluate cannabis products for key sensory attributes including appearance, flavor and aroma,” said Al Shefsky, CEO of Cannadigm. “As a community hub and trusted source for learning and teaching, LIT Research helps consumers and industry stakeholders to achieve their objectives through research and education.”
Motagon and PHCann International have made an agreement which will bring relief to Czech cannabis patients. Motagon, a Prague based pharmaceutical company will distribute PHCann’s range of dried flower and full spectrum extracts in personalized medicines.
“We are extremely pleased that in a relatively short period of time we have managed to commence the import, sale and distribution of high-quality medical cannabis to pharmacies in the form of dried flowers, but our aim from the start was to offer more effective forms such as extracts to Czech patients as soon as possible,” announced Jaromír Frič, MOTAGON’s chairman. “I believe that doctors and especially patients will appreciate this fundamental change, as well as the fact that there will be a broad extracts portfolio with a wide array of THC-CBD formulations, targeting a wider range of patients. “
BLAZE® Solutions Inc is proud to announce they have passed the SOC 1 Certification audit with its software. With the SOC 2 Type 1 Certification they received in July, BLAZE® is the first in the CannaTech industry to achieve dual SOC certifications.
“BLAZE® retailers can rest easy knowing that their data and their customer’s data are secure and the systems are handling data properly and are regularly audited,” relayed Kai Kirk, COO of BLAZE “As we see the cannabis space mature, many retailers will go through acquisitions, potentially with companies that demand high levels of security and compliance due to their investment structures. Running BLAZE® can give them peace of mind that they will not have to swap out their retail solution due to non-compliance and can continue moving fast in this ever-changing market.”
Press Release: https://www.newswire.ca/news-releases/blaze-r-becomes-the-first-cannabis-retail-software-to-receive-soc-1-certification-829918701.html
Innovation1 Biotech Inc has filed a provisional patent application for its novel and proprietary combination therapy targeting the addiction center of the brain. The therapy is designed to reset neural networks of addiction by suppressing withdrawal and cravings.
“Addiction affects millions of people nationwide and remains a thriving epidemic across the U.S. between nicotine, alcohol, substance abuse, prescription, and illegal drugs,” stated Dr. Andrew Salzman, Chief Science Officer of Innovation1 Biotech. “While each of these selected components have previously been utilized in experimental studies of addiction and drug withdrawal treatment, we believe this novel approach of combining the two will be much more effective in suppressing neuronal craving impulses. The two components each influence the alpha3beta4 nicotinic acetylcholine receptor, but do so in a different manner, thus making their combination profoundly impactful.”